Corticosteroid requirements in polymyalgia rheumatica.

@article{Weyand1999CorticosteroidRI,
  title={Corticosteroid requirements in polymyalgia rheumatica.},
  author={Cornelia M Weyand and James W Fulbright and Jonathan M. Evans and Gene G. Hunder and J{\"o}rg J Goronzy},
  journal={Archives of internal medicine},
  year={1999},
  volume={159 6},
  pages={577-84}
}
BACKGROUND Polymyalgia rheumatica (PMR) is a systemic inflammatory disease of unknown cause that affects older individuals. Clinical symptoms respond promptly to corticosteroids, but treatment is often required for several years, frequently resulting in adverse drug effects. Guidelines for the optimal use of corticosteroids that maximize relief of symptoms but minimize adverse effects of the therapy are needed. OBJECTIVE To determine whether clinical or laboratory parameters in PMR could be… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Similar Papers

Loading similar papers…